statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This Is What Whales Are Betting On Insmed

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update PR Newswire BRIDGEWATER, N.J., May 9...

Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update

Insmed To Present at the BofA Securities Health Care Conference 2024 Insmed To Present at the BofA Securities Health Care Conference 2024 PR Newswire BRIDGEWATER, N.J., May 7, 2024 BRIDGEWATER, N.J...

Insmed To Present at the BofA Securities Health Care Conference 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., May 3, 2024 BRIDGEWATER...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 PR Newswire...

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire BRIDGEWATER, N.J., April 5, 2024 BRIDGEWATER...

Passive investing in index funds can generate returns that roughly match the overall market. But you can significantly...

Insmed's (NASDAQ:INSM) investors will be pleased with their favorable 56% return over the last year

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Insmed added to 'Q2 Tactical Ideas List' at Wells Fargo

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annexon Biosciences (ANNX Research Report) and Insmed...

Analysts Are Bullish on Top Healthcare Stocks: Annexon Biosciences (ANNX), Insmed (INSM)

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference Insmed to Present New Data from Across its Respiratory Portfolio at the...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Watchers	1,776
52-Wk Low	$18.31
52-Wk High	$32.00

Volume	2.59M
52-Wk High	$32.00
52-Wk Low	$18.31

Period	Estimated	Reported	Surprise	Result
Q2'24	-$1.14	--	--	N/A
Q1'24	-$1.24	-$1.06	14.35%	BEAT
Q4'23	-$1.14	-$1.28	-11.98%	MISSED
Q3'23	-$1.14	-$1.11	2.72%	BEAT
Q2'23	-$1.13	-$1.78	-57.00%	MISSED

INSM Insmed Inc

About

Feed

News

Sentiment

Earnings

Fundamentals